- Illumina Lays Out Growth Roadmap After Grail Divestment🔍
- Illumina lays out growth roadmap after Grail divestment🔍
- Illumina CEO lays out growth plans after divesting Grail🔍
- GRAIL Archives🔍
- Grail to become an Illumina spinout once again🔍
- Illumina completes the divestiture of GRAIL🔍
- Illumina parts ways with Grail🔍
- ILLUMINA / GRAIL🔍
Illumina Lays Out Growth Roadmap After Grail Divestment
Illumina Lays Out Growth Roadmap After Grail Divestment - BioSpace
In a bid to win back investor confidence, Illumina on Tuesday unveiled a three-year growth plan focused on easier DNA sequencing and ...
Illumina lays out growth roadmap after Grail divestment - PharmaLive
In a bid to win back investor confidence, Illumina on Tuesday unveiled a three-year growth plan focused on easier DNA sequencing and ...
Illumina CEO lays out growth plans after divesting Grail - STAT News
Illumina lays out plan to boost growth by helping scientists interpret sequencing data ... SAN DIEGO — The unwinding of Illumina's ill-fated ...
... growth plan focused on easier DNA sequencing and improved data analysis for customers ... Illumina Lays Out Growth Roadmap After Grail Divestment.
U.S. gene sequencing company Illumina's plan to divest cancer diagnostic test maker Grail received the green light from EU antitrust regulators on Friday after ...
Grail to become an Illumina spinout once again, with plans to go public
The DNA sequencing giant has landed on a plan to spin out the cancer blood test company as an independent operation.
Illumina completes the divestiture of GRAIL
"With the completion of the spin-off of GRAIL, we have achieved our goal of divesting GRAIL in a manner that allows its breakthrough technology to continue ...
Illumina parts ways with Grail, with divestiture complete
... plan to obtain Grail, Illumina has cut (nearly) all ties ... Grail previously laid out its plans for a Nasdaq IPO in September 2020, after ...
ILLUMINA / GRAIL - European Commission
Today, the European Commission has approved, under the EU Merger Regulation ('EUMR'), Illumina's plan to divest GRAIL following the ...
Illumina Spin-Off Now Complete, Grail Sets Out on Its Own on the ...
A lot has happened since then, but Grail's goals remain similar: Expand access to its multi-cancer detection test by securing regulatory ...
Illumina in the News | What others say about us and our technology
Feb 26, 2024, Yicai Global, DNA Sequencing Giant Illumina Names Janssen Ex-Chairwoman as New SVP, China GM ; Feb 19, 2024, Nature, Super-speedy sequencing puts ...
EC Approves Illumina's Plan to Divest Cancer Diagnostics Maker Grail
After a years-long antitrust battle, the European Commission on Friday approved Illumina's plans to divest Grail. However, Illumina said ...
Grail CEO predicts 'transformative' 2024 amid Illumina split
The liquid biopsy maker, which Illumina plans to divest, said it has made progress on a PMA application with the FDA for its Galleri ...
Illumina completes Grail spinoff - MedTech Dive
Nearly four years after Illumina announced a deal to buy Grail, the liquid biopsy maker will debut on Nasdaq Tuesday as a standalone company.
Takeaways From the Illumina-Grail Merger Challenge Saga | Insights
Illumina announced in December that it would divest GRAIL, the result of a merger challenge with many twists and turns both in the United States and in Europe.
Illumina announces strategy to accelerate value creation
Illumina expects its strategy to enable the company to accelerate its revenue growth to high single digits by 2027. The Company aims to drive ...
US biotech Illumina faces potential $7bn loss from forced Grail sale
Although the spin-off is yet to occur, shareholders are allowed to begin trading the right to receive shares ahead of the divestment becoming ...
BioSpace - In a bid to win back investor confidence,... | Facebook
... growth plan focused on easier DNA sequencing and improved data analysis for customers. BIOSPACE.COM. Illumina Lays Out Growth Roadmap After Grail Divestment.
Illumina lays off 111 workers in San Diego - San Diego Union-Tribune
Illumina will divest Grail after losing battle with FTC. How did the San Diego biotech's $7B deal unravel?Illumina purchased Grail, a ...
Our results showed particularly strong demand for NovaSeqTM X and sequential revenue growth. The company also announced a commitment to further ...